Literature DB >> 27913416

Mutagenesis of NosM Leader Peptide Reveals Important Elements in Nosiheptide Biosynthesis.

Liang Jin1, Xuri Wu1, Yanjiu Xue1, Yue Jin1, Shuzhen Wang1, Yijun Chen2.   

Abstract

Nosiheptide, a typical member of the ribosomally synthesized and posttranslationally modified peptides (RiPPs), exhibits potent activity against multidrug-resistant Gram-positive bacterial pathogens. The precursor peptide of nosiheptide (NosM) is comprised of a leader peptide with 37 amino acids and a core peptide containing 13 amino acids. To pinpoint elements in the leader peptide that are essential for nosiheptide biosynthesis, a collection of mutants with unique sequence features, including N- and C-terminal motifs, peptide length, and specific sites in the leader peptide, was generated by mutagenesis in vivo The effects of various mutants on nosiheptide biosynthesis were evaluated. In addition to the necessity of a conserved motif LEIS box, native length and the N-terminal 12 amino acid residues were indispensable, and single-site substitutions of these 12 amino acid residues resulted in changes ranging from a greater-than-5-fold decrease to a 2-fold increase of nosiheptide production, depending on the sites and substituted residues. Moreover, although the C-terminal motif is not conservative, significant effects of this portion on nosiheptide production were also evident. Taken together, the present results further highlight the importance of the leader peptide in nosiheptide biosynthesis, and provide new insights into the diversity and specificity of leader peptides in the biosynthesis of various RiPPs. IMPORTANCE: As a representative thiopeptide, nosiheptide exhibits excellent antibacterial activity. Although the biosynthetic gene cluster and several modification steps have been revealed, the presence and roles of the leader peptide within the precursor peptide of the nosiheptide gene cluster remain elusive. Thus, identification of specific elements in the leader peptide can significantly facilitate the genetic manipulation of the gene cluster for increasing nosiheptide production or generating diverse analogues. Given the complexity of the biosynthetic process, the instability of the leader peptide, and the unavailability of intermediates, cocrystallization of intermediates, leader peptide, and modification enzymes is currently not feasible. Therefore, a mutagenesis approach was used to construct a series of leader peptide mutants to uncover a number of crucial and characteristic elements affecting nosiheptide biosynthesis, which moves a considerable distance toward a thorough understanding of the biosynthetic machinery for thiopeptides.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  RiPPs; antimicrobial peptide; bacterial metabolism; biosynthesis; leader peptide; mutagenesis; nosiheptide; thiopeptide

Mesh:

Substances:

Year:  2017        PMID: 27913416      PMCID: PMC5288820          DOI: 10.1128/AEM.02880-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  48 in total

1.  Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB.

Authors:  Manuel A Ortega; Yue Hao; Qi Zhang; Mark C Walker; Wilfred A van der Donk; Satish K Nair
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

2.  Moving posttranslational modifications forward to biosynthesize the glycosylated thiopeptide nocathiacin I in Nocardia sp. ATCC202099.

Authors:  Ying Ding; Yi Yu; Haixue Pan; Heng Guo; Yeming Li; Wen Liu
Journal:  Mol Biosyst       Date:  2010-05-17

3.  Substrate recognition and specificity of the NisB protein, the lantibiotic dehydratase involved in nisin biosynthesis.

Authors:  Antonino Mavaro; André Abts; Patrick J Bakkes; Gert N Moll; Arnold J M Driessen; Sander H J Smits; Lutz Schmitt
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 4.  From amino acids to heteroaromatics--thiopeptide antibiotics, nature's heterocyclic peptides.

Authors:  Rachael A Hughes; Christopher J Moody
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037.

Authors:  F Benazet; M Cartier; J Florent; C Godard; G Jung; J Lunel; D Mancy; C Pascal; J Renaut; P Tarridec; J Theilleux; R Tissier; M Dubost; L Ninet
Journal:  Experientia       Date:  1980-04-15

6.  Substrate-Tuned Catalysis of the Radical S-Adenosyl-L-Methionine Enzyme NosL Involved in Nosiheptide Biosynthesis.

Authors:  Xinjian Ji; Yongzhen Li; Wei Ding; Qi Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2015-07-03       Impact factor: 15.336

7.  Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.

Authors:  P Chen; F X Qi; J Novak; R E Krull; P W Caufield
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

8.  Effect of nosiheptide as a feed additive in chicks on the quantity, duration, prevalence of excretion, and resistance to antibacterial agents of Salmonella typhimurium; on the proportion of Escherichia coli and other coliforms resistant to antibacterial agents; and on their degree and spectrum of resistance.

Authors:  F Benazet; J R Cartier
Journal:  Poult Sci       Date:  1980-07       Impact factor: 3.352

9.  The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.

Authors:  Jerome Escano; Byron Stauffer; Jacob Brennan; Monica Bullock; Leif Smith
Journal:  Microbiologyopen       Date:  2014-11-17       Impact factor: 3.139

Review 10.  Follow the leader: the use of leader peptides to guide natural product biosynthesis.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  Nat Chem Biol       Date:  2010-01       Impact factor: 15.040

View more
  1 in total

Review 1.  Thiopeptides: antibiotics with unique chemical structures and diverse biological activities.

Authors:  Derek C K Chan; Lori L Burrows
Journal:  J Antibiot (Tokyo)       Date:  2020-12-21       Impact factor: 2.649

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.